CovIran Barekat proved effective on containing the UK variant of COVID-19

Iran officially announced that the COVID-19 vaccine developed by Iranian specialists, known as CovIran Barekat, has proven effective on containing the UK variant of COVID-19. Hassan Jalili, the head of the research group that developed the Iranian vaccine, told reporters on Saturday the vaccine has been successfully tested on the British variant, which is 70% more contagious than the common variant. “We tested the UK strain with the blood plasma of the three first volunteers vaccinated twice with CovIran Barekat,” he noted. “Their plasma was expected to be immune enough to counter the new strain. Our tests indicated that the Iranian vaccine has successfully managed to neutralize the mutated virus completely,” he added.